Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription

Detalhes bibliográficos
Autor(a) principal: Wang, Huawei
Data de Publicação: 2018
Outros Autores: Lapek, John, Fujimura, Ken, Strnadel, Jan, Liu, Bei, Gonzalez, David J., Zhang, Wei, Watson, Felicia, Yu, Vicky, Liu, Chao, Melo, Carina Muccilo [UNIFESP], Miller, Yury I., Elliott, Kathryn C., Cheresh, David A., Klemke, Richard L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/46022
http://dx.doi.org/10.1038/s41421-018-0024-3
Resumo: PEAK1 is a newly described tyrosine kinase and scaffold protein that transmits integrin-mediated extracellular matrix (ECM) signals to facilitate cell movement and growth. While aberrant expression of PEAK1 has been linked to cancer progression, its normal physiological role in vertebrate biology is not known. Here we provide evidence that PEAK1 plays a central role in orchestrating new vessel formation in vertebrates. Deletion of the PEAK1 gene in zebrafish, mice, and human endothelial cells (ECs) induced severe defects in new blood vessel formation due to deficiencies in EC proliferation, survival, and migration. Gene transcriptional and proteomic analyses of PEAK1-deficient ECs revealed a significant loss of vascular endothelial growth factor receptor 2 (VEGFR2) mRNA and protein expression, as well as downstream signaling to its effectors, ERK, Akt, and Src kinase. PEAK1 regulates VEGFR2 expression by binding to and increasing the protein stability of the transcription factor GATA-binding protein 2 (GATA2), which controls VEGFR2 transcription. Importantly, PEAK1-GATA2-dependent VEGFR2 expression is mediated by EC adhesion to the ECM and is required for breast cancer-induced new vessel formation in mice. Also, elevated expression of PEAK1 and VEGFR2 mRNA are highly correlated in many human cancers including breast cancer. Together, our findings reveal a novel PEAK1-GATA2-VEGFR2 signaling axis that integrates cell adhesion and growth factor cues from the extracellular environment necessary for new vessel formation during vertebrate development and cancer.
id UFSP_b9d67f04987e078b3045a0efd91b9b92
oai_identifier_str oai:repositorio.unifesp.br:11600/46022
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Wang, HuaweiLapek, JohnFujimura, KenStrnadel, JanLiu, BeiGonzalez, David J.Zhang, WeiWatson, FeliciaYu, VickyLiu, ChaoMelo, Carina Muccilo [UNIFESP]Miller, Yury I.Elliott, Kathryn C.Cheresh, David A.Klemke, Richard L.2018-07-26T12:18:44Z2018-07-26T12:18:44Z2018Cell Discovery. London, v. 4, p. -, 2018.2056-5968http://repositorio.unifesp.br/handle/11600/46022http://dx.doi.org/10.1038/s41421-018-0024-3WOS000433282700001.pdf10.1038/s41421-018-0024-3WOS:000433282700001PEAK1 is a newly described tyrosine kinase and scaffold protein that transmits integrin-mediated extracellular matrix (ECM) signals to facilitate cell movement and growth. While aberrant expression of PEAK1 has been linked to cancer progression, its normal physiological role in vertebrate biology is not known. Here we provide evidence that PEAK1 plays a central role in orchestrating new vessel formation in vertebrates. Deletion of the PEAK1 gene in zebrafish, mice, and human endothelial cells (ECs) induced severe defects in new blood vessel formation due to deficiencies in EC proliferation, survival, and migration. Gene transcriptional and proteomic analyses of PEAK1-deficient ECs revealed a significant loss of vascular endothelial growth factor receptor 2 (VEGFR2) mRNA and protein expression, as well as downstream signaling to its effectors, ERK, Akt, and Src kinase. PEAK1 regulates VEGFR2 expression by binding to and increasing the protein stability of the transcription factor GATA-binding protein 2 (GATA2), which controls VEGFR2 transcription. Importantly, PEAK1-GATA2-dependent VEGFR2 expression is mediated by EC adhesion to the ECM and is required for breast cancer-induced new vessel formation in mice. Also, elevated expression of PEAK1 and VEGFR2 mRNA are highly correlated in many human cancers including breast cancer. Together, our findings reveal a novel PEAK1-GATA2-VEGFR2 signaling axis that integrates cell adhesion and growth factor cues from the extracellular environment necessary for new vessel formation during vertebrate development and cancer.NIHNCIAHANIGMS/NIHRay Thomas Edwards FoundationUniv Calif San Diego, Dept Pathol, La Jolla, CA 92093 USAUniv Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USAUniv Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USAUniv Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USAUniv Calif San Diego, Dept Med, La Jolla, CA 92093 USAUniv Fed Sao Paulo, Dept Biochem, Sao Paulo, SP, BrazilUniv Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USAComenius Univ, Jessenius Fac Med Martin, Dept Mol Med, Biomed Ctr Martin, Martin 03601, SlovakiaUniv Fed Sao Paulo, Dept Biochem, Sao Paulo, SP, BrazilNIH: CA182495NIH: CA184594NIH: CA097022NIH: HL135737NIH: CA050286NCI: CA180374AHA: 16POST27250126NIGMS/NIH: K12GM068524Web of ScienceengNature Publishing GroupPseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcriptioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000433282700001.pdfapplication/pdf7462437${dspace.ui.url}/bitstream/11600/46022/1/WOS000433282700001.pdf0f5a00f606efbeb52b6ec22a5f83fd65MD51open accessTEXTWOS000433282700001.pdf.txtWOS000433282700001.pdf.txtExtracted texttext/plain93743${dspace.ui.url}/bitstream/11600/46022/2/WOS000433282700001.pdf.txt4f25343c036b826626697b257cdb5475MD52open accessTHUMBNAILWOS000433282700001.pdf.jpgWOS000433282700001.pdf.jpgIM Thumbnailimage/jpeg7057${dspace.ui.url}/bitstream/11600/46022/4/WOS000433282700001.pdf.jpgeda26d2aab020250afdde059c449ee5cMD54open access11600/460222022-08-02 11:10:24.045open accessoai:repositorio.unifesp.br:11600/46022Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652022-08-02T14:10:24Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
title Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
spellingShingle Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
Wang, Huawei
title_short Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
title_full Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
title_fullStr Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
title_full_unstemmed Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
title_sort Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
author Wang, Huawei
author_facet Wang, Huawei
Lapek, John
Fujimura, Ken
Strnadel, Jan
Liu, Bei
Gonzalez, David J.
Zhang, Wei
Watson, Felicia
Yu, Vicky
Liu, Chao
Melo, Carina Muccilo [UNIFESP]
Miller, Yury I.
Elliott, Kathryn C.
Cheresh, David A.
Klemke, Richard L.
author_role author
author2 Lapek, John
Fujimura, Ken
Strnadel, Jan
Liu, Bei
Gonzalez, David J.
Zhang, Wei
Watson, Felicia
Yu, Vicky
Liu, Chao
Melo, Carina Muccilo [UNIFESP]
Miller, Yury I.
Elliott, Kathryn C.
Cheresh, David A.
Klemke, Richard L.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Wang, Huawei
Lapek, John
Fujimura, Ken
Strnadel, Jan
Liu, Bei
Gonzalez, David J.
Zhang, Wei
Watson, Felicia
Yu, Vicky
Liu, Chao
Melo, Carina Muccilo [UNIFESP]
Miller, Yury I.
Elliott, Kathryn C.
Cheresh, David A.
Klemke, Richard L.
description PEAK1 is a newly described tyrosine kinase and scaffold protein that transmits integrin-mediated extracellular matrix (ECM) signals to facilitate cell movement and growth. While aberrant expression of PEAK1 has been linked to cancer progression, its normal physiological role in vertebrate biology is not known. Here we provide evidence that PEAK1 plays a central role in orchestrating new vessel formation in vertebrates. Deletion of the PEAK1 gene in zebrafish, mice, and human endothelial cells (ECs) induced severe defects in new blood vessel formation due to deficiencies in EC proliferation, survival, and migration. Gene transcriptional and proteomic analyses of PEAK1-deficient ECs revealed a significant loss of vascular endothelial growth factor receptor 2 (VEGFR2) mRNA and protein expression, as well as downstream signaling to its effectors, ERK, Akt, and Src kinase. PEAK1 regulates VEGFR2 expression by binding to and increasing the protein stability of the transcription factor GATA-binding protein 2 (GATA2), which controls VEGFR2 transcription. Importantly, PEAK1-GATA2-dependent VEGFR2 expression is mediated by EC adhesion to the ECM and is required for breast cancer-induced new vessel formation in mice. Also, elevated expression of PEAK1 and VEGFR2 mRNA are highly correlated in many human cancers including breast cancer. Together, our findings reveal a novel PEAK1-GATA2-VEGFR2 signaling axis that integrates cell adhesion and growth factor cues from the extracellular environment necessary for new vessel formation during vertebrate development and cancer.
publishDate 2018
dc.date.accessioned.fl_str_mv 2018-07-26T12:18:44Z
dc.date.available.fl_str_mv 2018-07-26T12:18:44Z
dc.date.issued.fl_str_mv 2018
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Cell Discovery. London, v. 4, p. -, 2018.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/46022
http://dx.doi.org/10.1038/s41421-018-0024-3
dc.identifier.issn.none.fl_str_mv 2056-5968
dc.identifier.file.none.fl_str_mv WOS000433282700001.pdf
dc.identifier.doi.none.fl_str_mv 10.1038/s41421-018-0024-3
dc.identifier.wos.none.fl_str_mv WOS:000433282700001
identifier_str_mv Cell Discovery. London, v. 4, p. -, 2018.
2056-5968
WOS000433282700001.pdf
10.1038/s41421-018-0024-3
WOS:000433282700001
url http://repositorio.unifesp.br/handle/11600/46022
http://dx.doi.org/10.1038/s41421-018-0024-3
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/46022/1/WOS000433282700001.pdf
${dspace.ui.url}/bitstream/11600/46022/2/WOS000433282700001.pdf.txt
${dspace.ui.url}/bitstream/11600/46022/4/WOS000433282700001.pdf.jpg
bitstream.checksum.fl_str_mv 0f5a00f606efbeb52b6ec22a5f83fd65
4f25343c036b826626697b257cdb5475
eda26d2aab020250afdde059c449ee5c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764134425559040